DLA Piper·FDA / LIFE SCIENCES REGULATORY
FDA Finalizes Guidance on Prescription Drug Use-Related Software
The FDA issued final guidance on October 20, 2026, setting out regulatory considerations for prescription drug use-related software and completing a process begun with a 2018 proposed framework and 2023 draft guidance.
fda-guidanceprescription-drug-use-related-softwarepdursdigital-healthsaasdevice-regulation
Read the original firm alert → Saturday, October 31, 2026